A detailed history of Beacon Investment Advisory Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 301,592 shares of NVO stock, worth $30.7 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares
301,592
Previous 306,608 1.64%
Holding current value
$30.7 Million
Previous $43.8 Million 17.95%
% of portfolio
1.51%
Previous 1.9%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $597,255 - $729,426
-5,016 Reduced 1.64%
301,592 $35.9 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $1.87 Million - $2.24 Million
-15,261 Reduced 4.74%
306,608 $43.8 Million
Q1 2024

May 09, 2024

SELL
$102.11 - $135.92 $1.14 Million - $1.52 Million
-11,151 Reduced 3.35%
321,869 $41.3 Million
Q4 2023

Feb 12, 2024

SELL
$87.78 - $105.45 $598,308 - $718,747
-6,816 Reduced 2.01%
333,020 $34.5 Million
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $14.8 Million - $32.4 Million
162,301 Added 91.42%
339,836 $30.9 Million
Q2 2023

Jul 21, 2023

SELL
$155.98 - $172.65 $1.2 Million - $1.33 Million
-7,683 Reduced 4.15%
177,535 $28.7 Million
Q1 2023

May 04, 2023

SELL
$132.34 - $159.14 $2.23 Million - $2.68 Million
-16,866 Reduced 8.35%
185,218 $29.5 Million
Q4 2022

Jan 13, 2023

SELL
$102.55 - $135.33 $235,352 - $310,582
-2,295 Reduced 1.12%
202,084 $0
Q3 2022

Oct 20, 2022

SELL
$95.28 - $116.93 $78,129 - $95,882
-820 Reduced 0.4%
204,379 $20.4 Million
Q2 2022

Jul 21, 2022

SELL
$103.24 - $121.81 $751,071 - $886,167
-7,275 Reduced 3.42%
205,199 $22.9 Million
Q1 2022

May 12, 2022

SELL
$93.1 - $112.54 $387,575 - $468,504
-4,163 Reduced 1.92%
212,474 $23.6 Million
Q4 2021

Feb 04, 2022

SELL
$95.88 - $117.08 $177,857 - $217,183
-1,855 Reduced 0.85%
216,637 $24.3 Million
Q3 2021

Nov 09, 2021

SELL
$84.42 - $106.62 $1.78 Million - $2.24 Million
-21,035 Reduced 8.78%
218,492 $21 Million
Q2 2021

Aug 02, 2021

SELL
$67.66 - $84.76 $529,845 - $663,755
-7,831 Reduced 3.17%
239,527 $20.1 Million
Q1 2021

May 21, 2021

SELL
$67.06 - $75.82 $244,769 - $276,743
-3,650 Reduced 1.45%
247,358 $16.7 Million
Q4 2020

Feb 08, 2021

SELL
$63.89 - $73.8 $619,157 - $715,195
-9,691 Reduced 3.72%
251,008 $17.5 Million
Q3 2020

Oct 29, 2020

SELL
$63.69 - $70.22 $50,506 - $55,684
-793 Reduced 0.3%
260,699 $18.1 Million
Q2 2020

Jul 28, 2020

SELL
$58.54 - $67.94 $190,255 - $220,805
-3,250 Reduced 1.23%
261,492 $17.1 Million
Q1 2020

May 05, 2020

SELL
$49.46 - $64.78 $3.5 Million - $4.59 Million
-70,783 Reduced 21.1%
264,742 $15.9 Million
Q4 2019

Jan 31, 2020

BUY
$49.86 - $58.26 $15.9 Million - $18.6 Million
319,325 Added 1971.14%
335,525 $19.4 Million
Q3 2019

Oct 29, 2019

BUY
$47.54 - $53.43 $770,148 - $865,566
16,200 New
16,200 $838,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Beacon Investment Advisory Services, Inc. Portfolio

Follow Beacon Investment Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.